2026 CVSL Reimbursement Updates for Boston Scientific Technologies

Webinar Description

Stay ahead of the 2026 Centers for Medicare & Medicaid Services (CMS) Final Rule changes with a fast, focused update designed for cardiovascular service line (CVSL) clinical, administrative and financial leaders. In this session, you'll get clear guidance on the documentation, coding and reimbursement shifts that matter most for high impact cardiovascular procedures, leveraging Boston Scientific’s key technologies:
• AGENT™ Drug Coated Balloon
• WATCHMAN™ LAAC Device
• FARAPULSE™ Pulsed Field Ablation System

Join us to learn how to:
• Strengthen documentation and coding accuracy
• Reduce denials and low payment risk
• Apply the most important 2026 reimbursement updates with confidence

Prepare your CVSL with the essentials needed to navigate 2026 successfully. Secure your spot today.

Speakers

Gaelle Wine, MBA, Senior Manager, Health Economics and Market Access, Boston Scientific
Lori Wukawitz, MHA, RN, Senior Manager Health Economics and Market Access, Boston Scientific

Moderator

Chris Romeo, Senior Vice President, Ventures, MedAxiom

Summary

Availability:

Registration Required

Location:

Online Meeting

Date / Time:

Feb 26, 2026 1:00 PM - 2:00 PM ET

Cost:

FREE

Credit Offered:

No Credit Offered